Get the Stockscreener App
3.265
1.72%
0.075
Orasure Technologies Inc stock is traded at $3.265, with a volume of 191.31K.
It is up +1.72% in the last 24 hours and up +15.48% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$3.19
Open:
$3.18
24h Volume:
191.31K
Relative Volume:
0.27
Market Cap:
$244.22M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
4.5347
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
+6.39%
1M Performance:
+15.48%
6M Performance:
-11.10%
1Y Performance:
-27.08%
1-Day Range:
$3.13
$3.2699
1-Week Range:
$3.01
$3.82
52-Week Range:
$2.36
$4.92
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.265 | 226.64M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
517.38 | 189.29B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
179.89 | 50.30B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.44 | 43.02B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.21 | 37.53B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.84 | 16.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again? - Smartkarma
Orasure gets takeover bid proposal from Ron Zwanziger- Reuters - MSN
How OraSure Technologies Inc. stock performs during market volatilityProfessional Stock Screener - Newser
CRISPR Diagnostics Market Growth is Powered by Rapid Genetic - openPR.com
OraSure Technologies received takeover bid from industry entrepreneur, sources say - NewsBreak: Local News & Alerts
Ron Zwanziger Proposes Takeover of OraSure TechnologiesNews and Statistics - IndexBox
OraSure Technologies: Riding the Catalyst Wave to Diagnostic Dominance - AInvest
OraSure Technologies Received Takeover Offer From Zwanziger - MarketScreener
Proteomic Blood Collection Devices - Trend Hunter
OraSure's Bold Move: How the Sherlock Acquisition Could Unlock a $1.5B Market and Fuel Explosive Growth - AInvest
OraSure Launches Blood Collection Tube For High-Quality Proteomic Research - Nasdaq
OraSure launches new blood collection device - WFMZ.com
OraSure Technologies Launches HEMAcollect™●PROTEIN for Advancements in Proteomic Research - Quiver Quantitative
OraSure Launches Novel Blood Collection Device for Proteomic Research - GlobeNewswire
Spire Wealth Management Acquires Shares of 16,010 OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Rapid Oral Fluid Screening Device Market | Fast, Non-Invasive - openPR.com
Assenagon Asset Management S.A. Increases Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Investor Network: OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire
Walgreens and KFF’s Greater Than Campaign to Offer Free HIV/STD Testing in Stores on June 27 - Financial Times
Robust Growth in Medtech Registration System Market - openPR.com
Two Sigma Investments LP Takes $552,000 Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Public Employees Retirement System of Ohio Acquires Shares of 76,602 OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Two Sigma Advisers LP Boosts Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Ameriprise Financial Inc. Has $628,000 Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Purchased by ProShare Advisors LLC - Defense World
Top Penny Stocks To Watch In May 2025 - simplywall.st
OraSure Technologies: Multiple Shots To Deliver Value (NASDAQ:OSUR) - Seeking Alpha
Millennium Management LLC Has $7.79 Million Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - marketscreener.com
OraSure (OSUR) Files for $300 Million Mixed Securities Offering - GuruFocus
Evercore says 23andMe buyout removes downside case for OraSure - Yahoo Finance
OraSure Technologies (NASDAQ:OSUR) Receives “In-Line” Rating from Evercore ISI - Defense World
Jane Street Group LLC Has $1.47 Million Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure rises as seen benefitting from 23andMe/Regeneron deal - MSN
OraSure Technologies (OSUR) Rises on Regeneron-23andMe Deal - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition - Investing.com
OraSure Technologies (OSUR) Maintains In-Line Rating with Everco - GuruFocus
Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties - TipRanks
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | - GuruFocus
OraSure Technologies (OSUR) Sees Positive Market Reaction | OSUR Stock News - GuruFocus
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | OSUR Stock News - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition By Investing.com - Investing.com India
OraSure’s Board of Directors has a new Member Stephen S. Tang, Ph.D., has joined OraSure T - Medical Product Outsourcing
OraSure Technologies (NASDAQ:OSUR) Raised to Hold at StockNews.com - Defense World
Tower Research Capital LLC TRC Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Targeted Genomics, OraSure in pact for at-home celiac genetic testing - MSN
10,227 Shares in OraSure Technologies, Inc. (NASDAQ:OSUR) Bought by Raymond James Financial Inc. - Defense World
Voya Investment Management LLC Sells 28,998 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies Approves Stock Plan Amendment at Annual Meeting - TipRanks
OraSure, Targeted Genomics in pact for at-home celiac genetic testing - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac T - GuruFocus
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):